Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria : an open-label randomized controlled trial CAN KNOW

• Main Authors: Grigg, Matthew J., William, Timothy, Barber, Bridget E., Rajahram, Giri S., Menon, Jayaram, Schimann, Emma, Wilkes, Christopher S., Patel, Kaajal, Chandna, Arjun, Price, Ric N., Yeo, Tsin Wen, Anstey, Nicholas M.
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2020
• Subjects: Science::Medicine; Plasmodium Knowlesi; Malaria
• Online Access: https://hdl.handle.net/10356/142353
• Institution: Nanyang Technological University

Background: Plasmodium knowlesi is reported increasingly across Southeast Asia and is the most common cause of malaria in Malaysia. No randomized trials have assessed the comparative efficacy of artemether-lumefantrine (AL) for knowlesi malaria. Methods: A randomized controlled trial was conducted i...